Teams with the ability to optimize commercial launch readiness through insight, differentiation, efficiency and risk mitigation will lead the pack.
TORONTO (PRWEB) July 17, 2020
Commercial launch readiness is a critical stage in a product life cycle. While the world hangs on pharma’s ability to discover a COVID cure or vaccine, the global economic downturn will only increase price pressures overall for the industry. The era of increasing competitive and price pressure is not going away and capturing full value from every product launch is critical. However, history shows that only a third of product launches meet analyst expectations. Teams with the ability to optimize commercial launch readiness through insight, differentiation, efficiency and risk mitigation will lead the pack.
Often teams, whether in a start-up, mid, or large pharma, lack extensive experience in commercial launch readiness. This influences the brand’s ability to meet forecast and achieve market access targets.
Leveraging the breadth and depth of launch experience from scores of launches across primary care, rare disease, oncology and specialty, this webinar will discuss typical commercial launch readiness risk areas, best practices approaches for commercial readiness and securing market access and measurement.
For more information or to register for this event, visit Pharmaceutical Commercial Launch Readiness, Secrets to De-Risk and Accelerate Success.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.